PLAY PODCASTS
Challenging Scenarios: Managing a First ART Failure
Episode 299

Challenging Scenarios: Managing a First ART Failure

Listen as an expert uses a case scenario to discuss how to manage first ART failure in a patient with COVID-19, including guideline recommendations and data for resistance testing and choosing a new ART regimen, as well as considerations for drug‒drug interactions.

Decera Clinical Education Infectious Disease Podcast · Renslow Sherer MD

July 26, 202318m 4s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Renslow Sherer, MD, discusses managing a first ART failure in the setting of COVID-19, including:

  • Guideline recommendations for resistance testing
  • Guideline recommendations for selecting a new ART regimen
  • Data on retained efficacy of NRTIs in second-line regimens in the EARNEST and NADIA studies
  • Consideration of drug‒drug interactions between ART and COVID-19 treatment

Presenter: 
Renslow Sherer, MD
Director 
International HIV Training Center 
Professor of Medicine 
Section of Infectious Diseases and Global Health 
Department of Medicine 
University of Chicago 
Chicago, Illinois 

To download the slides: https://bit.ly/3OcqxIE 

To view the full online program: https://bit.ly/3ZjSFhg


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

treatment experienceddolutegravirnucleoside reverse transcriptase inhibitorintegrase inhibitorpidtgart failureantiretroviral therapyvaccinedarunavirdrvearnestgenotypingdrug-drug interactionnadiacovid-19instiresistanceproviral dnanrtirecycling nrtisartprotease inhibitorhivsecond-line artnirmatrelvir/ritonavirimmunocompromised